Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies - PubMed (original) (raw)
Comparative Study
Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies
J P Moore et al. J Virol. 1994 Jan.
Abstract
We have probed the structures of monomeric and oligomeric gp120 glycoproteins from the LAI isolate of human immunodeficiency virus type 1 (HIV-1) with a panel of monoclonal antibodies (MAbs); most of these MAbs are directed against continuous epitopes. On native monomeric gp120, most of the first conserved (C1) domain is accessible to MAbs, although some regions of C1 are relatively inaccessible. All of the MAbs directed against the C2, C3, and C5 domains bind preferentially to denatured monomeric gp120, indicating that these regions of gp120 are poorly accessible on the native monomer, although the extreme C terminus in C5 is well exposed. Segments of the V1, V2, and V3 loops are exposed on the surface of monomeric gp120, although the base of the V3 loop is inaccessible. A portion of C4 is also available for MAb binding on monomeric gp120, as is the extreme C terminus in C5. However, on oligomeric gp120-gp41 complexes, only the V2 and V3 loops (and perhaps V1) are well exposed and a segment of the C4 region is partially exposed; continuous epitopes in C1 and C5 that are accessible to antibodies on monomeric gp120 are occluded on the oligomer. Although deletion of the V1, V2, and V3 loops resulted in increased exposure of several discontinuous epitopes overlapping the CD4-binding site, the exposure of most continuous epitopes on the monomeric gp120 glycoprotein was not affected. These results imply a HIV-1 gp120 structure in which the conserved continuous determinants are inaccessible; in some cases, this inaccessibility is due to intramolecular interactions between conserved regions, and in other cases, it is due to intermolecular interactions with other components of the glycoprotein spike. These findings have implications for the design of subunit vaccines based on gp120.
Similar articles
- Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains.
Moore JP, Sattentau QJ, Yoshiyama H, Thali M, Charles M, Sullivan N, Poon SW, Fung MS, Traincard F, Pinkus M, et al. Moore JP, et al. J Virol. 1993 Oct;67(10):6136-51. doi: 10.1128/JVI.67.10.6136-6151.1993. J Virol. 1993. PMID: 7690418 Free PMC article. - Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities.
Earl PL, Broder CC, Long D, Lee SA, Peterson J, Chakrabarti S, Doms RW, Moss B. Earl PL, et al. J Virol. 1994 May;68(5):3015-26. doi: 10.1128/JVI.68.5.3015-3026.1994. J Virol. 1994. PMID: 7512157 Free PMC article. - Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.
Nyambi PN, Mbah HA, Burda S, Williams C, Gorny MK, Nádas A, Zolla-Pazner S. Nyambi PN, et al. J Virol. 2000 Aug;74(15):7096-107. doi: 10.1128/jvi.74.15.7096-7107.2000. J Virol. 2000. PMID: 10888650 Free PMC article. - Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
Richardson TM Jr, Stryjewski BL, Broder CC, Hoxie JA, Mascola JR, Earl PL, Doms RW. Richardson TM Jr, et al. J Virol. 1996 Feb;70(2):753-62. doi: 10.1128/JVI.70.2.753-762.1996. J Virol. 1996. PMID: 8551612 Free PMC article.
Cited by
- Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
Dupuy FP, Kant S, Barbé A, Routy JP, Bruneau J, Lebouché B, Tremblay C, Pazgier M, Finzi A, Bernard NF. Dupuy FP, et al. mBio. 2019 Dec 17;10(6):e02690-19. doi: 10.1128/mBio.02690-19. mBio. 2019. PMID: 31848282 Free PMC article. - Neutralization tiers of HIV-1.
Montefiori DC, Roederer M, Morris L, Seaman MS. Montefiori DC, et al. Curr Opin HIV AIDS. 2018 Mar;13(2):128-136. doi: 10.1097/COH.0000000000000442. Curr Opin HIV AIDS. 2018. PMID: 29266013 Free PMC article. Review. - Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.
Richard J, Pacheco B, Gohain N, Veillette M, Ding S, Alsahafi N, Tolbert WD, Prévost J, Chapleau JP, Coutu M, Jia M, Brassard N, Park J, Courter JR, Melillo B, Martin L, Tremblay C, Hahn BH, Kaufmann DE, Wu X, Smith AB 3rd, Sodroski J, Pazgier M, Finzi A. Richard J, et al. EBioMedicine. 2016 Oct;12:208-218. doi: 10.1016/j.ebiom.2016.09.004. Epub 2016 Sep 9. EBioMedicine. 2016. PMID: 27633463 Free PMC article. - HIV - 1 SUBTYPES, ITS IMPLICATIONS AND VIRAL DYNAMICS.
Sahni AK, Nagendra A, Menon PK. Sahni AK, et al. Med J Armed Forces India. 2002 Jan;58(1):66-9. doi: 10.1016/S0377-1237(02)80017-X. Epub 2011 Jul 21. Med J Armed Forces India. 2002. PMID: 27365663 Free PMC article. - Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region.
Tolbert WD, Gohain N, Veillette M, Chapleau JP, Orlandi C, Visciano ML, Ebadi M, DeVico AL, Fouts TR, Finzi A, Lewis GK, Pazgier M. Tolbert WD, et al. Structure. 2016 May 3;24(5):697-709. doi: 10.1016/j.str.2016.03.005. Epub 2016 Mar 31. Structure. 2016. PMID: 27041594 Free PMC article.
References
- Science. 1985 May 3;228(4699):593-5 - PubMed
- Science. 1985 May 31;228(4703):1091-4 - PubMed
- Nature. 1985 Jul 4-10;316(6023):69-72 - PubMed
- Science. 1990 Sep 28;249(4976):1533-44 - PubMed
- J Virol. 1990 Dec;64(12):5701-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous